Alliance A081105: Non-Small Cell Lung Cancer (NSCLC) - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults with non-small cell lung cancer who:
- Have completely resected non-squamous non-small cell lung cancer
- Have no history of cornea abnormalities
- Are not pregnant or nursing
What is Involved?
If you choose to join this study, you will:
- Be randomized (like the flip of a coin) and get either:
-- Group 1: The study drug erlotinib for up to 2 years
-- Group 2: Observation; will not get erlotinib but will be followed by their study doctor
-- Get a CT scan and clinic visits every 6 months for the first 4 years and then yearly for the following 6 years for up to 10 years from the start of the study